PERSPECTA

News from every angle

← Back to headlines

Nektar Therapeutics Files Nasdaq Inducement Grant Disclosure

Nektar Therapeutics announced equity inducement grants issued under Nasdaq Listing Rule 5635(c)(4) to attract and retain key employees and directors.

28 Aug, 20:33 — 28 Aug, 20:33
PostShare

Sources

Showing 1 of 1 sources
morningstar1d ago

Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Morningstar

Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)  Morningstar

Read full article →

Related Stories

South Korean Retail Investors Shift Billions to US Stocks Amid ETF Curbs

59m ago

HDFC Bank CEO Sashidhar Jagdishan to Step Down in October

3h ago

FSSAI Bans Everest and Laljee Godhoo From Selling Substandard Hing Powder

4h ago

UAE Central Bank Launches Probe Into Banque Misr Over US Money Laundering Warnings

5h ago